These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 24929172)
1. Dose escalation, not “new biology,” can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer. In reply to Rao et al. Brown JM; Carlson DJ; Brenner DJ Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):693-4. PubMed ID: 24929172 [No Abstract] [Full Text] [Related]
2. Dose escalation, not “new biology,” can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer. In regard to Brown et al. Rao SS; Oh JH; Jackson A; Deasy JO Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):692-3. PubMed ID: 24929171 [No Abstract] [Full Text] [Related]
3. Dose escalation, not "new biology," can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer. Brown JM; Brenner DJ; Carlson DJ Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1159-60. PubMed ID: 23517805 [No Abstract] [Full Text] [Related]
4. Stereotactic ablative radiation therapy for centrally located recurrences of non-small cell lung cancer: in regard to Chang et al. Oskan F Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1141-1142. PubMed ID: 25035222 [No Abstract] [Full Text] [Related]
5. [Stereotactic body radiation therapy for early non-small cell lung cancer]. Zhang HQ; Li MH; Yu JM Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):561-3. PubMed ID: 22325212 [No Abstract] [Full Text] [Related]
6. Pattern of failure following chemoradiation for locally advanced non-small cell lung cancer: potential role for stereotactic body radiotherapy. Nguyen NP; Bishop M; Borok TJ; Welsh J; Hamilton R; Cohen D; Nguyen LM; Vincent VH Anticancer Res; 2010 Mar; 30(3):953-61. PubMed ID: 20393019 [TBL] [Abstract][Full Text] [Related]
10. Sublobar/wedge resection or stereotactic body radiation therapy for stage I marginally operable non-small-cell lung cancer. Suppiah S; Linden P; Robke J; Schroeder C; Yao M; Machtay M; Lo SS Expert Rev Anticancer Ther; 2012 Nov; 12(11):1375-7. PubMed ID: 23249103 [No Abstract] [Full Text] [Related]
11. Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes. Hadziahmetovic M; Loo BW; Timmerman RD; Mayr NA; Wang JZ; Huang Z; Grecula JC; Lo SS Discov Med; 2010 May; 9(48):411-7. PubMed ID: 20515609 [TBL] [Abstract][Full Text] [Related]
12. Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer. Aridgides P; Bogart J Thorac Surg Clin; 2016 Aug; 26(3):261-9. PubMed ID: 27427521 [TBL] [Abstract][Full Text] [Related]
13. Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer. Abbas G; Danish A; Krasna MJ Surg Oncol Clin N Am; 2016 Jul; 25(3):553-66. PubMed ID: 27261915 [TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiation therapy as a derivative of stereotactic radiosurgery: clinically independent but with enduring common themes. Kavanagh BD J Clin Oncol; 2014 Sep; 32(26):2827-31. PubMed ID: 25113758 [No Abstract] [Full Text] [Related]